![](/img/cover-not-exists.png)
Efficacy and Safety of Once-Weekly Semaglutide vs. Exenatide ER after 56 Weeks in Subjects with Type 2 Diabetes (SUSTAIN 3)
Hramiak, Irene, Ahmann, Andrew, Capethorn, Matthew, Charpentier, Guillaume, Dotta, Francesco, Lingvay, Elena Henkelildiko, Holst, Anders Gaarsdal, Annett, Miriam, Aroda, Vanita R.Volume:
40
Language:
english
Journal:
Canadian Journal of Diabetes
DOI:
10.1016/j.jcjd.2016.08.114
Date:
October, 2016
File:
PDF, 374 KB
english, 2016